These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 24884842

  • 1. Urinary soluble urokinase receptor levels are elevated and pathogenic in patients with primary focal segmental glomerulosclerosis.
    Huang J, Liu G, Zhang YM, Cui Z, Wang F, Liu XJ, Chu R, Zhao MH.
    BMC Med; 2014 May 20; 12():81. PubMed ID: 24884842
    [Abstract] [Full Text] [Related]

  • 2. Relationship between serum soluble urokinase plasminogen activator receptor level and steroid responsiveness in FSGS.
    Li F, Zheng C, Zhong Y, Zeng C, Xu F, Yin R, Jiang Q, Zhou M, Liu Z.
    Clin J Am Soc Nephrol; 2014 Nov 07; 9(11):1903-11. PubMed ID: 25318750
    [Abstract] [Full Text] [Related]

  • 3. Recurrent Primary Focal Segmental Glomerulosclerosis Managed With Intensified Plasma Exchange and Concomitant Monitoring of Soluble Urokinase-Type Plasminogen Activator Receptor-Mediated Podocyte β3-integrin Activation.
    Staeck O, Slowinski T, Lieker I, Wu K, Rudolph B, Schmidt D, Brakemeier S, Neumayer HH, Wei C, Reiser J, Budde K, Halleck F, Khadzhynov D.
    Transplantation; 2015 Dec 07; 99(12):2593-7. PubMed ID: 26371597
    [Abstract] [Full Text] [Related]

  • 4. Primary and Recurrent Focal Segmental Glomerulosclerosis Closely Link to Serum Soluble Urokinase-type Plasminogen Activator Receptor Levels.
    Jin J, Li YW, He Q.
    Transplant Proc; 2015 Dec 07; 47(6):1760-5. PubMed ID: 26293047
    [Abstract] [Full Text] [Related]

  • 5. Urine but not serum soluble urokinase receptor (suPAR) may identify cases of recurrent FSGS in kidney transplant candidates.
    Franco Palacios CR, Lieske JC, Wadei HM, Rule AD, Fervenza FC, Voskoboev N, Garovic VD, Zand L, Stegall MD, Cosio FG, Amer H.
    Transplantation; 2013 Aug 27; 96(4):394-9. PubMed ID: 23736353
    [Abstract] [Full Text] [Related]

  • 6. Plasma soluble urokinase receptor levels are increased but do not distinguish primary from secondary focal segmental glomerulosclerosis.
    Huang J, Liu G, Zhang YM, Cui Z, Wang F, Liu XJ, Chu R, Chen Y, Zhao MH.
    Kidney Int; 2013 Aug 27; 84(2):366-72. PubMed ID: 23447064
    [Abstract] [Full Text] [Related]

  • 7. A reassessment of soluble urokinase-type plasminogen activator receptor in glomerular disease.
    Spinale JM, Mariani LH, Kapoor S, Zhang J, Weyant R, Song PX, Wong HN, Troost JP, Gadegbeku CA, Gipson DS, Kretzler M, Nihalani D, Holzman LB, Nephrotic Syndrome Study Network.
    Kidney Int; 2015 Mar 27; 87(3):564-74. PubMed ID: 25354239
    [Abstract] [Full Text] [Related]

  • 8. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis.
    Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, Maiguel D, Karumanchi SA, Yap HK, Saleem M, Zhang Q, Nikolic B, Chaudhuri A, Daftarian P, Salido E, Torres A, Salifu M, Sarwal MM, Schaefer F, Morath C, Schwenger V, Zeier M, Gupta V, Roth D, Rastaldi MP, Burke G, Ruiz P, Reiser J.
    Nat Med; 2011 Jul 31; 17(8):952-60. PubMed ID: 21804539
    [Abstract] [Full Text] [Related]

  • 9. Soluble Urokinase Receptor Levels Are Correlated with Focal Segmental Glomerulosclerosis Lesions in IgA Nephropathy: A Cohort Study from China.
    Guo SM, Han M, Chen MX, Ning Y, Pei GC, Li YQ, Dai W, Ge SW, Deng YJ, Guo YY, Li XQ, Haller H, Xu G, Rong S.
    PLoS One; 2015 Jul 31; 10(9):e0138718. PubMed ID: 26380984
    [Abstract] [Full Text] [Related]

  • 10. Serum suPAR in patients with FSGS: trash or treasure?
    Maas RJ, Deegens JK, Wetzels JF.
    Pediatr Nephrol; 2013 Jul 31; 28(7):1041-8. PubMed ID: 23515666
    [Abstract] [Full Text] [Related]

  • 11. CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance.
    Cara-Fuentes G, Wei C, Segarra A, Ishimoto T, Rivard C, Johnson RJ, Reiser J, Garin EH.
    Pediatr Nephrol; 2014 Aug 31; 29(8):1363-71. PubMed ID: 24263531
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic and Prognostic Value of Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) in Focal Segmental Glomerulosclerosis and Impact of Detection Method.
    Winnicki W, Sunder-Plassmann G, Sengölge G, Handisurya A, Herkner H, Kornauth C, Bielesz B, Wagner L, Kikić Ž, Pajenda S, Reiter T, Schairer B, Schmidt A.
    Sci Rep; 2019 Sep 24; 9(1):13783. PubMed ID: 31551522
    [Abstract] [Full Text] [Related]

  • 13. Soluble Urokinase Receptor Levels in Secondary Focal Segmental Glomerulosclerosis.
    Sun P, Yu L, Huang J, Wang S, Zou W, Yang L, Liu G.
    Kidney Dis (Basel); 2019 Oct 24; 5(4):239-246. PubMed ID: 31768381
    [Abstract] [Full Text] [Related]

  • 14. [Value of soluble urokinase receptor serum levels in the differential diagnosis between idiopathic and secondary focal segmental glomerulosclerosis].
    Segarra A, Jatem E, Quiles MT, Arbós MA, Ostos H, Valtierra N, Carnicer C, Salcedo MT.
    Nefrologia; 2014 Oct 24; 34(1):53-61. PubMed ID: 24463863
    [Abstract] [Full Text] [Related]

  • 15. Identifying a potential biomarker for primary focal segmental glomerulosclerosis and its association with recurrence after transplantation.
    Harel E, Shoji J, Abraham V, Miller L, Laszik Z, Thurison T, King A, Olshen A, Leung J, Szabo G, Hann B, Høyer-Hansen G, Craik CS, Vincenti F.
    Clin Transplant; 2019 Mar 24; 33(3):e13487. PubMed ID: 30689221
    [Abstract] [Full Text] [Related]

  • 16. CD80, suPAR and nephrotic syndrome in a case of NPHS2 mutation.
    Cara-Fuentes G, Araya C, Wei C, Rivard C, Ishimoto T, Reiser J, Johnson RJ, Garin EH.
    Nefrologia; 2013 Mar 24; 33(5):727-31. PubMed ID: 24089165
    [Abstract] [Full Text] [Related]

  • 17. Serum soluble urokinase-type plasminogen activator receptor levels and idiopathic FSGS in children: a single-center report.
    Bock ME, Price HE, Gallon L, Langman CB.
    Clin J Am Soc Nephrol; 2013 Aug 24; 8(8):1304-11. PubMed ID: 23620441
    [Abstract] [Full Text] [Related]

  • 18. Plasma Soluble Urokinase Receptor Level Is Correlated with Podocytes Damage in Patients with IgA Nephropathy.
    Zhao Y, Liu L, Huang J, Shi S, Lv J, Liu G, Zhao M, Zhang H.
    PLoS One; 2015 Aug 24; 10(7):e0132869. PubMed ID: 26167688
    [Abstract] [Full Text] [Related]

  • 19. Management of severe recurrent focal segmental glomerulosclerosis through circulating soluble urokinase receptor modification.
    Morath C, Wei C, Macher-Goeppinger S, Schwenger V, Zeier M, Reiser J.
    Am J Ther; 2013 Aug 24; 20(2):226-9. PubMed ID: 23466622
    [Abstract] [Full Text] [Related]

  • 20. Patients With Combined Membranous Nephropathy and Focal Segmental Glomerulosclerosis Have Comparable Clinical and Autoantibody Profiles With Primary Membranous Nephropathy: A Retrospective Observational Study.
    Gu QH, Cui Z, Huang J, Zhang YM, Qu Z, Wang F, Wang X, Wang SX, Liu G, Zhao MH.
    Medicine (Baltimore); 2016 May 24; 95(21):e3786. PubMed ID: 27227951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.